Dr Kumar says it's not just the question of his safety or survival but that of 'my precious big cats'.
Sun Pharma was by far the biggest gainer in the Sensex pack, surging 8.13 per cent, followed by Dr Reddy's at 4.92 per cent.
Also, with Sonia Gandhi, Rahul Gandhi and Priyanka Gandhi Vadra not in the running for the party president's post, a non-Gandhi would be at the helm after over 24 years following the polling on Monday and counting on Wednesday.
'We cannot have bodies putrefying in water.' 'This is a health hazard and it can create a very inflammatory situation.'
'It is absolutely important for us to continue to message to people that they must wear masks, keep physical distancing, as much as is practically possible, at work or at home.'
Stress is one of the leading causes of premature greying, warns Dr Monica Chahar.
The movie star took a break from a film shoot in Amritsar to visit a BSF campus.
TCS, Bajaj Auto, Adani Ports and Cipla were the top gainers on BSE Sensex while Coal India, GAIL, Dr Reddy's and Infosys lost the most on the index.
'If you were to say today that the government should appoint judges to the high courts and Supreme Court, then I think that even those few good judges that we are getting today we would not get them.'
Such businesses outperform non-family firms by 3% in first six months of CY20, says Credit Suisse report.
'...only if we sort it out with Pakistan.'
Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation.
Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With More drugmakers in line to launch the drug soon, the prices may see a further erosion.
The 50-share NSE Nifty after moving between 10,374.30 and 10,307.30 settled flat at 10,348.75, up 6.45 points, or 0.06 per cent.
Polarisation and the increase in index weight of a few a stocks have weighed on performance. The worst performers include Nippon India Large Cap and HDFC Top 100 (2.6 per cent).
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Indian equity markets registered their highest single-day percentage gains since early October.
While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.
The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the conventional model to produce immune response. Instead, they carry molecular instructions to make the protein in the body through a synthetic RNA of the virus.
Results of some blue-chip companies exceeded expectations, providing additional thrust, traders said.
'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'
Soon after the above government order was released, the Opposition strongly condemned the move.
Infosys, TCS, HUL and Reliance Industries were the top gainers of the day.
"Sputnik will probably offer vaccines after June 20. They will start the vaccine production from the month of August. They are importing the vaccines right now, and they will allot a section of their imported vaccines to the Delhi government," he said.
'In today's launch, the 'Pralay' missile was tested for heavier payload and different range to prove the precision and lethality of the weapon'
The NSE 50-share after moving between 10,309.85 and 10,261.50 on alternate bouts of selling and buying, finished at 10,298.75, with paltry gains of 15.15 points, or 0.15 per cent.
This firing is a significant step towards achieving self-reliance in niche missile technology. Navy said.
It said clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
The average age of the new Union council of ministers has reduced to 58 years from 61 years previously following Wednesday's reshuffle.
The growth was led by family-owned companies and business groups with presence in pharmaceuticals, information technology services, and consumer products.
Describing the mission as a "major milestone" in the development of BrahMos, the sources said that the air version of the missile was test-fired from supersonic fighter aircraft Sukhoi 30 MK-I at 10.30 am.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
Among major Sensex gainers, ITC rose the most by 2.32 per cent, followed by TCS, M&M, SBI and Bharti Airtel.
In a range-bound trading, the BSE benchmark Sensex ended a shade higher by 1.57 points in the special 90-minute trading today as funds refrained from making any major commitments in the absence of global cues.
Nadella advised the start-up community to learn from the failures
'Officers have been made the scapegoat for political failure.' 'No effort has been made to find out who scuttled the prime minister's decision to introduce competitive bidding and why and at whose instance.'
Five vaccine candidates are in advanced stages of development in India, out of which four are in Phase II/III and one is in Phase-I/II trials.
On the sectoral front, rate-sensitive sectors such as Bankex and Auto gained by 1% and 0.7% respectively while BSE Consumer Durables gained 1.4%.
Investors lost Rs 2 trillion as Sensex crashed on Tuesday.
Motherson Sumi, Tata Steel, Jaguar Land Rover will face higher cost.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances